Literature DB >> 23771675

Correlation between enhanced intensity of atherosclerotic plaque at contrast-enhanced ultrasonography and density of histological neovascularization.

Jie Sun1, Kun Liu1, Qiao-Ying Tang1, Wei Zhang1, You-Bin Deng2.   

Abstract

The feasibility of contrast-enhanced ultrasonography in the assessment of atherosclerotic plaque neovascularization and its relation to histological findings were investigated. Abdominal aortic atherosclerotic plaque model was induced in 25 New Zealand white rabbits by a combination of high cholesterol-rich diet and balloon aortic denudation. Standard and contrast-enhanced ultrasonography was performed at the 16th week of the model induction period. The plaques were classified as echogenic plaques or echolucent plaques according to their echogenicity at standard ultrasonography. The maximum thickness of plaque was measured in the longitudinal section. Time intensity curve was used to quantify the enhanced intensity of the plaque. Animals were euthanized and abdominal aortas were harvested for histological staining of CD31 to evaluate the neovascularization density of atherosclerotic plaque. The results showed that the echolucent plaques had higher enhanced intensity during contrastenhanced ultrasonography and higher neovascularization density at CD31 staining than the echogenic plaques. The enhanced intensity of atherosclerotic plaque and its ratio to lumen were well correlated with histological neovascularization density (r=0.75, P<0.001; r=0.68, P<0.001, respectively). However, the maximum thickness of plaque was not correlated with neovascularization density (r=0.235, P=0.081). These findings demonstrated that the enhanced intensity in the plaque and ratio of enhanced intensity to that in the lumen of abdominal aorta may be more accurate in the evaluation of plaque neovascularization than maximum thickness. Our study indicates that contrast-enhanced ultrasonography provides us a reliable method for the evaluation of plaque neovascularization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23771675     DOI: 10.1007/s11596-013-1139-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  16 in total

Review 1.  Neovascularization in human atherosclerosis.

Authors:  Pedro R Moreno; K-Raman Purushothaman; Marc Sirol; Andrew P Levy; Valentin Fuster
Journal:  Circulation       Date:  2006-05-09       Impact factor: 29.690

2.  Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US.

Authors:  Daniel Staub; Sasan Partovi; Arend F L Schinkel; Blai Coll; Heiko Uthoff; Markus Aschwanden; Kurt A Jaeger; Steven B Feinstein
Journal:  Radiology       Date:  2010-10-22       Impact factor: 11.105

3.  Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity.

Authors:  Stefano Coli; Marco Magnoni; Giuseppe Sangiorgi; Massimiliano M Marrocco-Trischitta; Giulio Melisurgo; Alessandro Mauriello; Luigi Spagnoli; Roberto Chiesa; Domenico Cianflone; Attilio Maseri
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

Review 4.  Contrast enhanced ultrasound imaging.

Authors:  Steven B Feinstein; Blai Coll; Daniel Staub; Dan Adam; Arend F L Schinkel; Folkert J ten Cate; Kai Thomenius
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

5.  Carotid plaque vulnerability: quantification of neovascularization on contrast-enhanced ultrasound with histopathologic correlation.

Authors:  Assaf Hoogi; Dan Adam; Aaron Hoffman; Hedviga Kerner; Shimon Reisner; Diana Gaitini
Journal:  AJR Am J Roentgenol       Date:  2011-02       Impact factor: 3.959

6.  Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI.

Authors:  Roberto Corti; Julio Osende; Randolph Hutter; Juan F Viles-Gonzalez; Urooj Zafar; Carolina Valdivieso; Gabor Mizsei; John T Fallon; Valentin Fuster; Juan J Badimon
Journal:  Atherosclerosis       Date:  2006-04-05       Impact factor: 5.162

Review 7.  Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques.

Authors:  Daniel Staub; Arend F L Schinkel; Blai Coll; Stefano Coli; Antonius F W van der Steen; Jess D Reed; Christian Krueger; Kai E Thomenius; Dan Adam; Eric J Sijbrands; Folkert J ten Cate; Steven B Feinstein
Journal:  JACC Cardiovasc Imaging       Date:  2010-07

Review 8.  The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond.

Authors:  Steven B Feinstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

9.  Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.

Authors:  Earl S Ford; Simon Capewell
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

10.  Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms.

Authors:  Li Xiong; You-Bin Deng; Ying Zhu; Ya-Ni Liu; Xiao-Jun Bi
Journal:  Radiology       Date:  2009-03-20       Impact factor: 11.105

View more
  2 in total

1.  Correlation of enhancement degree on contrast-enhanced ultrasound with histopathology of carotid plaques and serum high sensitive C-reactive protein levels in patients undergoing carotid endarterectomy.

Authors:  Li Xiong; Wei-Jun Sun; Hua-Ying Cai; Yuan Yang; Jiang Zhu; Bo-Wen Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

2.  The therapeutic effect of bevacizumab on plaque neovascularization in a rabbit model of atherosclerosis during contrast-enhanced ultrasonography.

Authors:  Yang Li; Ying Zhu; Youbin Deng; Yani Liu; Yuhang Mao; Junli Wang; Jie Sun
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.